Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL1242832 | 0.89 | FFAR3 (0.34) | FFAR3 | |
| Malonic Acid SCHEMBL27973934 | 0.84 | LDHA (0.41) | — | |
| Glycolic Acid SCHEMBL21635478 | 0.84 | — | — | |
| Acetic Acid SCHEMBL9630666 | 0.84 | FFAR3 (0.35) | FFAR3 | |
| Bicarbonate SCHEMBL5682507 | 0.84 | — | — | |
| Bicarbonate SCHEMBL1563325 | 0.84 | — | — | |
| Thioglycolic Acid SCHEMBL28058106 | 0.83 | — | — | |
| SCHEMBL28860134 | 0.82 | TSHR (0.34) | — | |
| Acetone SCHEMBL4541424 | 0.81 | — | — | |
| Benzene SCHEMBL29022973 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140004043-A1 | CRYPTOPHANE DERIVATIVES AND METHODS OF USE THEREOF | GEORGETOWN UNIVERISTY (US) | 2014-01-02 | — | — | US | disclosed |
| US-8222022-B2 | Tri-functionalized cryptophane biosensors | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2012-07-17 | — | — | US | disclosed |
| WO-2012051323-A2 | CRYPTOPHANE DERIVATIVES AND METHODS OF USE THEREOF | GEORGETOWN UNIVERSITY (US) | 2012-04-19 | — | — | WO | disclosed |
| US-20100105099-A1 | TRI-FUNCTIONALIZED CRYPTOPHANE, SYNTHESIS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105099-A1 | TRI-FUNCTIONALIZED CRYPTOPHANE, SYNTHESIS AND USES THEREOF | SPR, CACYBP, CRY2 | FFAR3 1883/4885 |
| US-20140004043-A1 | CRYPTOPHANE DERIVATIVES AND METHODS OF USE THEREOF | CRY2, CRY1, CRYAB | FFAR3 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.